M/24/001 – EQT/Zeus

Transaction details

The proposed acquisition of indirect sole control of Zeus Company Inc. by EQT Fund Management S.à r.l, acting as fund manager for and on behalf of the entities forming the investment fund EQT X has been cleared by the Competition and Consumer Protection Commission.

Notification date Decision date
Thursday January 4, 2024 Wednesday, January 24, 2024
Parties Involved Business activities
EQT Fund Management S.à r.l.

EQT Fund Management S.à r.l. ("EFMS") acts as fund manager for and on behalf of the entities forming the investment fund EQT X.

EQT X

EQT X consists of a group of private equity funds that invests in portfolio companies in Europe, Asia, and the US, and is active in a variety of industries.

Zeus Company Inc.

Zeus Company Inc. ("Zeus") is a medical technology company involved in the global supply of polymer
solutions, including tubing, catheter componentry, heat shrinks, bioabsorbable and
implantable medical products, sutures, and fiber optics, for a number of applications,
predominantly in medical, but including some activities in aerospace, automotive, and
energy.

In the State, Zeus operates a manufacturing plant in Letterkenny, County Donegal.

Economic sector Media merger
Healthcare No
Submissions from third parties due by:
Phase 1 Phase 2
Thursday, January 18, 2024
Current status: Completed
Simplified Merger Notification
Authorised Officer Assigned Contact Details
Louis O'Carroll

louisocarroll@ccpc.ie

Media enquiries: communications@ccpc.ie

Return to Merger Notifications

Haven’t found what you’re looking for?